Results 201 to 210 of about 56,983 (273)

Markers of Type 2 Inflammation and Immunosenescence Are Upregulated in Localized Scleroderma. [PDF]

Int J Mol Sci
Khoury L, Prosty C, Ghazal S, Gabrielli S, Torok KS, Osman M, Martinez-Jaramillo E, Lefrançois P, Netchiporouk E.   +8 more
europepmc   +1 more source

Scleroderma

Dermatology Online Journal, 2001
openaire   +2 more sources

Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study. [PDF]

Rheumatology (Oxford)
De Luca G, De Lorenzis E, Campochiaro C, Cacciapaglia F, Del Papa N, Zanatta E, Airò P, Lazzaroni MG, Giuggioli D, De Santis M, Alonzi G, Stano S, Binda M, Moccaldi B, Tonutti A, Cavalli S, Batani V, Natalello G, Iannone F, D'Agostino MA, Dagna L, Matucci-Cerinic M, Bosello SL.   +22 more
europepmc   +1 more source

Association of Black Race with Demographic, Comorbidities, and Outcome Variables in Localized Scleroderma Patients: A Retrospective Analysis of the 2017 US National Inpatient Sample. [PDF]

Dermatol Pract Concept
Kumar KD, Desai AD, Lipner SR.
europepmc   +1 more source

Unusual Cutaneous Manifestations in a Patient with a History of Hepatitis B: A Case of Scleromyxedema and Literature Review. [PDF]

Clin Cosmet Investig Dermatol
Gao A, Tian X, Lang D, Chen Y.
europepmc   +1 more source

Clinical Image: A Novel Capillaroscopic Morphologic Anomaly in a Smoker: The "∩-Shaped" Megacapillary. [PDF]

ACR Open Rheumatol
Nigro A.
europepmc   +1 more source

Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease. [PDF]

J Scleroderma Relat Disord
Khanna D, Evnin LB, Assassi S, Benton WW, Gordon G, Maslova K, Steffgen J, Maher TM.   +7 more
europepmc   +1 more source

Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial. [PDF]

Rheumatology (Oxford)
Fernández-Codina A, Nevskaya T, Baron M, Appleton CT, Cecchini MJ, Philip A, El-Shimy M, Vanderhoek L, Pinal-Fernández I, Pope JE.   +9 more
europepmc   +1 more source